Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Hum Genet ; 62(4): 855-64, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9529340

ABSTRACT

The DAX1 protein is an orphan nuclear hormone receptor based on sequence similarity in the putative ligand-binding domain (LBD). DAX1 mutations result in X-linked adrenal hypoplasia congenita (AHC). Our objective was to identify DAX1 mutations in a series of families, to determine the types of mutations resulting in AHC and to locate single-amino-acid changes in a DAX1 structural model. The 14 new mutations identified among our 17 families with AHC brought the total number of families with AHC to 48 and the number of reported mutations to 42; 1 family showed gonadal mosaicism. These mutations included 23 frameshift, 12 nonsense, and six missense mutations and one single-codon deletion. We mapped the seven single-amino-acid changes to a homology model constructed by use of the three-dimensional crystal structures of the thyroid-hormone receptor and retinoid X receptor alpha. All single-amino-acid changes mapped to the C-terminal half of the DAX1 protein, in the conserved hydrophobic core of the putative LBD, and none affected residues expected to interact directly with a ligand. We conclude that most genetic alterations in DAX1 are frameshift or nonsense mutations and speculate that the codon deletion and missense mutations give insight into the structure and function of DAX1.


Subject(s)
DNA-Binding Proteins/chemistry , DNA-Binding Proteins/genetics , Mutation , Receptors, Retinoic Acid/chemistry , Receptors, Retinoic Acid/genetics , Repressor Proteins , Transcription Factors/chemistry , Transcription Factors/genetics , X Chromosome , Adrenal Glands/abnormalities , Amino Acid Sequence , DAX-1 Orphan Nuclear Receptor , Genetic Linkage , Humans , Hypogonadism/genetics , Molecular Sequence Data , Sequence Analysis , Structure-Activity Relationship
2.
Infect Control Hosp Epidemiol ; 18(4): 230-6, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9131364

ABSTRACT

OBJECTIVE: To evaluate the risk of phlebitis associated with chlorhexidine-coated polyurethane catheters in peripheral veins. DESIGN: A randomized, double-blinded trial comparing chlorhexidine-coated polyurethane catheters with uncoated polyurethane catheters. SETTING: A university hospital. PATIENTS: Adult medicine and surgery patients. INTERVENTIONS: Certified registered nurse anesthetists or an infusion team consisting of nurses and physicians inserted the catheters. Catheter insertion sites were scored twice daily for evidence of phlebitis. At the time catheters were removed, a quantitative blood culture was performed, and catheters were sonicated for quantitative culture. RESULTS: Of 221 evaluable catheters, phlebitis developed in 18 (17%) of 105 coated catheters, compared to 27 (23%) of 116 uncoated catheters (relative risk [RR], 0.74; 95% confidence interval [CI95], 0.43-1.26; P = .32). By survival analysis, chlorhexidine-coated catheters had a lower risk of phlebitis during the first 3 days (P = .06), but not when all catheters were considered in both patient groups (P = .31). In the absence of catheter colonization, the incidence of phlebitis was 21% (16/76) and 24% (20/86) for coated and uncoated catheters, respectively (P = .85), whereas in the presence of catheter colonization, the incidence of phlebitis was 14% (1/7) and 80% (4/5) for coated and uncoated catheters, respectively (RR, 0.18; CI95, 0.03-1.15; P = .07). CONCLUSION: The risk of phlebitis in the presence of catheter colonization was 82% lower for chlorhexidine-coated polyurethane catheters compared to otherwise identical uncoated catheters.


Subject(s)
Anti-Infective Agents, Local/administration & dosage , Catheterization, Peripheral/adverse effects , Catheters, Indwelling/microbiology , Chlorhexidine/administration & dosage , Cross Infection/prevention & control , Equipment Contamination/prevention & control , Phlebitis/prevention & control , Adult , Catheterization, Peripheral/methods , Catheters, Indwelling/adverse effects , Confidence Intervals , Double-Blind Method , Female , Humans , Infection Control/methods , Infection Control/standards , Male , Proportional Hazards Models , Prospective Studies , Risk , Sample Size , Staphylococcus/isolation & purification , Survival Analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...